INDICATIONS

  • Severe bronchospasm
  • Use slow bolus injection in patient with life-threatening features ONLY. See Asthma guideline

PREPARATIONS

  • Salbutamol injection 500 microgram in 1 mL ampoule, dilute for slow IV bolus injection
  • Salbutamol solution for IV infusion 5 mg in 5 mL ampoule (1 mg/mL), dilute before use

DILUENTS

  • Sodium chloride 0.9% or glucose 5%

ADMINISTRATION

IV bolus injection

  • For use in patient with life-threatening features ONLY

Preparation

  • Use 500 microgram in 1 mL preparation
    • take 0.5 mL. Make up to 20 mL with diluent in a Luer lock syringe (see Diluents) = 12.5 microgram/mL

Dosage

  • IV bolus of 250 micrograms over 10 min
    • administer via a syringe driver at a rate of 120 mL/hr = 2 mL/min

IV infusion

  • Use this regimen for patients with non-life-threatening features
  • Note that the concentration is different from the IV bolus injection guidance above

Preparation

  • Use preparation for IV infusion (5 mg in 5 mL)
  • Remove 5 mL from a 500 mL bag of diluent (see Diluents)
    • add 5 mL (5 mg) of salbutamol to the bag = 5 mg in 500 mL = 10 microgram/mL

Dosage

  • Initial rate = 5 microgram/min
  • Adjust rate according to response and heart rate
    • usual range:3–20 microgram/min or more if necessary

Pump rate for selected dose

IV infusion (5 mg salbutamol in 500 mL)

Enter dose required (microgram/min):

MONITORING

  • Heart rate
    • salbutamol increases heart rate with possible palpitations preventing dosage increase
  • Cardiac monitoring is advised in patients with ischaemic heart disease
  • Check plasma potassium 1–2 hr after starting IV salbutamol and after each dosage increase
    • salbutamol causes rapid cellular uptake of potassium, which can lead to serious hypokalaemia

© 2022 The Bedside Clinical Guidelines Partnership.

Created by University Hospital North Midlands and Keele University School of Computing and Mathematics.

Research and development team: James Mitchell, Ed de Quincey, Charles Pantin, Naveed Mustfa